16:09 EDT MBX Biosciences (MBX) files automatic mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MBX:
- MBX Biosciences reports Q4 EPS (49c), consensus (63c)
- MBX Biosciences appoints Basbaum as Chief Business Officer
- MBX Biosciences Advances Canvuparatide After Phase 2 FDA Meeting
- MBX Biosciences ‘on track’ to initiate Phase 3 in Q3 following EOP 2 meeting
- MBX Biosciences Announces CFO Transition and Interim Appointment